FDA (6,900 employees, $6.5B budget) regulates drugs, devices, and biologics across 20% of US consumer spending. Approved first-ever gene therapy for genetic hearing loss under National Priority Voucher Program in 2026 and issued draft guidance on genome editing safety standards to accelerate gene therapy development.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edit suggestions, or content requests - sent directly to James.